Dr. James Robert Lepage Jr.
D.O. | Psychiatry | 8+ years Exp
1015 Montlimar Dr Ste A210, Mobile
Alabama, 36609-1743
251-461-4243 251-450-4323
Maps & DirectionsDr. James Robert Lepage Jr. is a Mobile, Alabama based psychiatrist with 8 years of experience in Psychiatry. He completed his graduation from Alabama College Of Osteopathic Medicine in 2017. He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. James Robert Lepage Jr. is DO.1938 for Psychiatry in Alabama. His current practice location is 1015 Montlimar Dr Ste A210, Mobile. Patients can reach him at 251-461-4243 or can fax him at 251-450-4323. Dr. James Robert Lepage Jr. is D.O. in Psychiatry and his NPI number (Unique professional ID assigned by NPPES) is 1083146922.
Dr. James Robert Lepage Jr. specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.
Complete Profile:
Dr. James Robert Lepage Jr. speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
| Name: | Dr. James Robert Lepage Jr. |
| Specialization: | Psychiatry |
| Gender: | Male |
| Credentials: | D.O. |
| Experience: | 8+ years |
| Medical School Attended: | Alabama College Of Osteopathic Medicine |
| Graduation Year: | 2017 |
| Accepts Medicare Assignment: | Yes |
| Practice Address: | 1015 Montlimar Dr Ste A210, Mobile,
Alabama, 36609-1743 |
| Phone: | 251-461-4243 |
| Fax: | 251-450-4323 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| PAC ID: | 5395003388 |
| Enrollment ID: | I20190805001259 |
| NPI Number: | 1083146922 |
| NPI Enumeration Date: | 30 Mar, 2017 |
| NPI Last Update On: | 11 Jul, 2022 |
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. James Robert Lepage Jr. are as mentioned below.
| License Number | Specialization | State | Status | |
| DO.1938 | Psychiatry | Alabama | Primary | |
| Student in an Organized Health Care Education/Training Program | | Secondary | |
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Dr. James Robert Lepage Jr. is associated with along with the number of members in that group.
| Organization Name (Group PAC ID) | Members |
| Altapointe Health Systems Inc (1052224052) | 49 |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Dr. James Robert Lepage Jr.
1015 Montlimar Dr Ste A210,
Mobile, Alabama |
| Zip: | 36609-1743 |
| Phone Number: | 251-461-4243 |
| Fax Number: | 251-450-4323 |
Patients can reach Dr. James Robert Lepage Jr. at
1015 Montlimar Dr Ste A210, Mobile, Alabama or can
call to book an appointment on 251-461-4243.
Comments/ Reviews:
Read all the reviews posted for Dr. James Robert Lepage Jr. below. You may also share your own experience with Dr. James Robert Lepage Jr.. Your feedback can help others make better decisions.
*
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.